Intrinsiqq
GSK plc logo

GSK plc Dividend Analysis

GSK.XLON

⊜ Compare
Dividend59

Does GSK (GSK.XLON) pay a dividend?

Safe dividend, income-oriented

Yes. GSK (GSK.XLON) pays a dividend: £0.67 per share over the last twelve months, a dividend yield of 3.56% at the latest close.

It has raised its dividend per share for 3 years in a row, shrinking at 6.8% a year over the last 5 years. The payout takes about 52.0% of earnings.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

73

Safety

40% of composite

Earnings Payout80
52.0%Sustainable
FCF Coverage65
1.9xAdequate
23

Growth

35% of composite

Dividend Streak45
3YGrowing recently
Growth Rate0
-6.8%Declining
85

Income

25% of composite

Cash Yield (TTM)85
3.56%Above average

Composite = Safety (73) × 0.40 + Growth (23) × 0.35 + Income (85) × 0.25 = 59

Dividend Safety

Earnings Payout

52.0%

FCF Payout

51.3%

FCF Coverage

1.9x

Dividend Growth

Per Share (TTM)

£0.67

Growth Streak

3 years

5Y CAGR

-6.8%

Dividend history

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025£0.67+8.1%
2024£0.62+5.1%
2023£0.59+2.2%
2022£0.58-50.7%
2021£1.17+23.0%
2020£0.95-23.8%
2019£1.250.0%
2018£1.250.0%
2017£1.250.0%
2016£1.250.0%

Newest 10 of 32 fiscal years; the chart above has the full series. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend Income

Annual DPS (TTM)

£0.67

Annual Income / £10K

£356

Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.

Yield History

GSK (GSK.XLON) dividend: yield, safety and growth

Frequently asked

Does GSK (GSK.XLON) pay a dividend, and how much?+

Yes, GSK pays a regular dividend of about £0.67 per share per year (a yield of roughly 3.6%). That is a payout ratio of about 52.0% of earnings, so it is covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.

Is GSK's dividend safe?+

GSK's dividend looks covered by free cash flow, with free cash flow covering the payout about 1.9 times over. Intrinsiqq scores its dividend safety at 73 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.

Has GSK grown its dividend?+

GSK has raised its dividend for about 3 years in a row. Recent dividend growth has been roughly flat. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.

What is GSK's dividend payout ratio?+

GSK pays out about 52.0% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.

Peers

Drug Manufacturers - General · Pick stocks to compare with GSK.XLON

CompareIntrinsic value
AZN.XLONAstraZeneca PLC
£140.32+1.98%56
HIK.XLONHikma Pharmaceuticals
£17.50+0.41%39
SBMFFSino Biopharmaceutical Limited
$0.67+0.00%74
002630.XKRXOrientbio Inc.
₩1,197.00+1.96%26
SOBI.XSTOSwedish Orphan Biovitrum AB
kr 482.00+0.31%40
EL.XPAREssilorLuxottica SA
€189.10+2.63%43
DEMANT.XCSEDemant A/S
kr 375.08+2.34%68
SHL.XETRSiemens Healthineers AG
€44.85+3.46%65

Held by ETFs

GSK.XLON is in 160 US ETFs. The largest of them, with GSK.XLON's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GSK.XLON

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.